[Usage of beta-adrenolytic agents in patients with chronic pulmonary obstructive disease].
Beta-blockers are commonly used in the contemporary pharmacotherapy. They are considered the drugs of choice in the treatment of many, especially cardiological, disorders. Chronic obstructive pulmonary disease (COPD) is a very common disease, which is classified as the fourth cause of the chronic morbidity and mortality in the USA. Frequent occurrence, as well as the fact that some risk factors, such as cigarette smoking, are common for both COPD and cardiovascular diseases cause that the number of patients suffering from their coexistence is increasing. Because first beta-blockers had a strong bronchoconstrictory effect, their use is contraindicated in conditions associated with airway obstruction. This review was aimed to investigate the safety of using of beta-blockers in patients with COPD. We try to answer whether selective beta-blockers and so-called hybrid beta-blockers are safe for patients suffering from this disorder. We also try to elaborate some therapeutic recommendations.
Bułdak
Łukasz
Ł
Slaski Uniwersytet Medyczny, Klinika Chorób Wewnetrznych i Farmakologii Klinicznej. boolean@poczta.onet.pl
Duława
Anna
A
Krysiak
Robert
R
Okopień
Bogusław
B
D058671:Adrenergic beta-1 Receptor Antagonists; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D016896:Treatment Outcome
D058671:Adrenergic beta-1 Receptor Antagonists; D000319:Adrenergic beta-Antagonists